Loading clinical trials...

Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection | Clinical Trials | Clareo Health

Back to clinical trial search

TERMINATEDPhase 2NCT01756924

Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection

To determine if oral antibiotic treatment with CEM-102 and Rifampin is as effective and safe as the standard of care antibiotic therapy for the treatment of hip and knee prosthetic joint or spacer inf...

Lead sponsor: Arrevus Inc.•13 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Active Not RecruitingPhase 1/2

Bacteriophage Therapy for Methicillin-Sensitive Staphylococcus Aureus Prosthetic Joint Infection

NCT06456424 · Prosthetic Joint Infections of Hip, Staphylococcus Aureus Infection

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 19, 2019Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment14

Start dateDec 2012

Last updatedApr 19, 2019

Condition

Prosthetic Joint Infections of Hip Prosthetic Joint Infections of Knee Infected Spacers

Locations shown

Sarasota, Florida

Tamarac, Florida

Savannah, Georgia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 19, 2019Data synced to Clareo: May 17, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions